MECP2 and atypical Rett syndrome: Both miR-155 and miR-802 target the methyl CpG binding protein 2 (MeCP2) (Kuhn et al., 2010), which is associated with deleterious effects on development as seen in Rett Syndrome (Cohen et al., 2003).